~~<i id='CAC5D24A25'><strike id='CAC5D24A25'><tt id='CAC5D24A25'><pre id='CAC5D24A25'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

leisure time

author：focus 2025-10-06 06:37:59 - browse：63

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Inside the rise of 'mukbang' eating videos

entertainment

hotspot

focus

1:29PoliceandanimalcontrolofficersinEdwardsville,Kansas,workedtogetherwiththeBonnerSpringsPoliceDepa

WSS

New warning issued for rebooking air travel after delays, cancellations

How dance can help health care workers heal from trauma

Millions may soon lose Medicaid when they don't have to

FDA approves first new drug developed for postpartum depression

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

The kidney, in all its complexity, is captured in a new atlas

focus

leisure time

entertainment

Medicare details structure of new drug price negotiation program

Trump got a 'target letter.' What is one and what does it mean?

Bright Health sells Medicare Advantage business to Molina

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

Duchenne breakthrough therapy leaves behind pioneering families

FDA approves first new drug developed for postpartum depression

Virginia high school admissions case could be legal follow

Novo: Oral version of Ozempic leads to 15% weight loss

Hollywood unions extend contract negotiations for actors

Sea level rise could wash away turtle breeding grounds around the world, researchers say

hotspot

Biogen nominates mother of director’s child to replace him on board

Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

Plane’s emergency slide plummets from sky, hits Chicago home

Man who had jail sentence commuted by Trump arrested again

Biden administration plans revamp of organ transplant system

focus

focus

focus

focus